Increased prevalence of levofloxacin-resistant Mycobacterium tuberculosis in China is associated with specific mutations within the gyrA gene. (March 2020)
- Record Type:
- Journal Article
- Title:
- Increased prevalence of levofloxacin-resistant Mycobacterium tuberculosis in China is associated with specific mutations within the gyrA gene. (March 2020)
- Main Title:
- Increased prevalence of levofloxacin-resistant Mycobacterium tuberculosis in China is associated with specific mutations within the gyrA gene
- Authors:
- Huo, Fengmin
Zhang, Fuzhen
Xue, Yi
Shang, Yuanyuan
Liang, Qian
Ma, Yifeng
Li, Yunxu
Zhao, Liping
Pang, Yu - Abstract:
- Highlights: An alarming increase in prevalence of FQ-resistant TB is observed in China over the past decade. This dynamic change in FQ resistance is majorly attributed to the increase of high-level LFX-resistance. A significant difference is noted in the proportion of LFX-resistant isolates harboring specific mutations within gyrA gene between 2005 and 2015. Abstract: Objectives: To compare the prevalence of levofloxacin (LFX) resistance and the population structure of Mycobacterium tuberculosis (MTB) with different mutations conferring LFX resistance between 2005 and 2015. Methods: A total 542 MTB isolates were randomly selected from pulmonary tuberculosis (TB) patients in 2005 and 2015 and analyzed regarding minimum inhibitory concentrations (MICs) and quinolone resistance-determining regions (QRDR). Results: One hundred and eleven of the 542 MTB isolates analyzed (20.5%) were resistant to LFX. There were 42 and 69 LFX-resistant isolates from 2005 and 2015, respectively, and MIC high-level LFX resistance was significantly higher in 2015 (40.6%, 28/69) than in 2005 (16.7%, 7/42) ( p = 0.02). There were 87 (78.4%) mutations of these 111 LFX-resistant isolates. In addition, a significant difference in proportion was observed in the isolates with mutations in codon 90 of the gyrA gene between 2005 and 2015 (11.9% in 2005 versus 29.0% in 2015, p = 0.04). Conclusions: There was an alarming increase in prevalence of LFX-resistant TB in China between 2005 and 2015. This dynamicHighlights: An alarming increase in prevalence of FQ-resistant TB is observed in China over the past decade. This dynamic change in FQ resistance is majorly attributed to the increase of high-level LFX-resistance. A significant difference is noted in the proportion of LFX-resistant isolates harboring specific mutations within gyrA gene between 2005 and 2015. Abstract: Objectives: To compare the prevalence of levofloxacin (LFX) resistance and the population structure of Mycobacterium tuberculosis (MTB) with different mutations conferring LFX resistance between 2005 and 2015. Methods: A total 542 MTB isolates were randomly selected from pulmonary tuberculosis (TB) patients in 2005 and 2015 and analyzed regarding minimum inhibitory concentrations (MICs) and quinolone resistance-determining regions (QRDR). Results: One hundred and eleven of the 542 MTB isolates analyzed (20.5%) were resistant to LFX. There were 42 and 69 LFX-resistant isolates from 2005 and 2015, respectively, and MIC high-level LFX resistance was significantly higher in 2015 (40.6%, 28/69) than in 2005 (16.7%, 7/42) ( p = 0.02). There were 87 (78.4%) mutations of these 111 LFX-resistant isolates. In addition, a significant difference in proportion was observed in the isolates with mutations in codon 90 of the gyrA gene between 2005 and 2015 (11.9% in 2005 versus 29.0% in 2015, p = 0.04). Conclusions: There was an alarming increase in prevalence of LFX-resistant TB in China between 2005 and 2015. This dynamic change is mostly attributed to the increase in high-level LFX resistance. Moreover, a significant difference was noted in the proportion of LFX-resistant isolates harboring specific mutations within the gyrA gene between 2005 and 2015. … (more)
- Is Part Of:
- International journal of infectious diseases. Volume 92(2020)
- Journal:
- International journal of infectious diseases
- Issue:
- Volume 92(2020)
- Issue Display:
- Volume 92, Issue 2020 (2020)
- Year:
- 2020
- Volume:
- 92
- Issue:
- 2020
- Issue Sort Value:
- 2020-0092-2020-0000
- Page Start:
- 241
- Page End:
- 246
- Publication Date:
- 2020-03
- Subjects:
- Tuberculosis -- Levofloxacin -- Drug resistance -- gyrA -- China
Communicable diseases -- Periodicals
Communicable Diseases -- Periodicals
Communicable diseases
Periodicals
Electronic journals
616.9 - Journal URLs:
- http://bibpurl.oclc.org/web/73769 ↗
http://www.journals.elsevier.com/international-journal-of-infectious-diseases/ ↗
http://www.sciencedirect.com/science/journal/12019712 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/12019712 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/12019712 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ijid.2020.01.021 ↗
- Languages:
- English
- ISSNs:
- 1201-9712
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.304750
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13399.xml